Login to Your Account



Teva Invests $10M In Proneuron, Buys Into Expanded Use Of COP-1


Wednesday, December 12, 2001
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription